USPTO Rejects

On January 18, 2024, the USPTO rejected a "contingent" terminal disclaimer filed by Acadia Pharmaceuticals Inc. (Acadia) for a patent it owns...

Related Keywords

Delaware ,United States , ,Acadia Pharmaceuticals Inc ,Pharmaceuticals Inc ,Aurobindo Pharma Ltd ,Acadia Pharmaceuticals ,Abbreviated New Drug Application ,Orange Book Listed ,Patent Term Adjustment ,Patent Term ,Contingent Terminal Disclaimer ,Terminal Disclaimer ,Contingent Terminal ,Federal Circuit ,Mondaq ,Uspto Rejects Quot Contingent Terminal Disclaimer ,Intellectual Property ,Patent ,Litigation ,Ediation Amp Arbitration ,Trials Amp Appeals Compensation ,